Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study

The effect of route of administration on the enantioselective pharmacokinetics of ketamine and norketamine in rats

(2018) Martin Le Nedelec et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders

(2018) Paul Glue et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders

(2017) Paul Glue et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

(2017) Jerome H Taylor et al.   NEUROPSYCHOPHARMACOLOGY

Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression

(2016) C. K. Loo et al.   ACTA PSYCHIATRICA SCANDINAVICA

Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy

(2016) Marko A. Peltoniemi et al.   CLINICAL PHARMACOKINETICS

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

(2015) Ying Xu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder

(2014) Adriana Feder et al.   JAMA Psychiatry

Ketamine as a new treatment for depression: A review of its efficacy and adverse effects

(2013) Natalie Katalinic et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

(2013) C. N. Haile et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept

(2013) Carolyn I Rodriguez et al.   NEUROPSYCHOPHARMACOLOGY

Enantioselective pharmacokinetics of (R)- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome

(2010) Michael E. Goldberg et al.   CHIRALITY